LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 12, Issue 1, 2002, Pages 19-23

  Gylling, H ^a   Miettinen, T A ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cholesterol absorption; Cholesterol synthesis; Cholestyramine; Plant stanol esters; Serum sterols; Simvastatin

Indexed keywords

BILE ACID; CHOLESTEROL; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; SITOSTEROL; SITOSTEROL DERIVATIVE; STANOL ESTER;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD; CHOLESTEROL INTAKE; CORONARY ARTERY ATHEROSCLEROSIS; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE ABSORPTION; LOW FAT DIET; MALE; METABOLISM; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTYRAMINE; CORONARY ARTERIOSCLEROSIS; DIET, FAT-RESTRICTED; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL ABSORPTION; MALE; SIMVASTATIN; SITOSTEROLS; TREATMENT OUTCOME;

EID: 0036464008     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Grundy SM (1988) HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 319: 24-33
2. Gylling H, Miettinen TA (1996) The effects of inhibiting cholesterol synthesis and absorption on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin dependent diabetic men. J Lipid Res 37: 1776-1785
3. Gylling H, Rajaratnam R, Miettinen TA (1997) Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Circulation 96: 4226-4231
4. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502
5. Miettinen TA (1970) Detection of changes in human cholesterol metabolism. Ann Clin Res 2: 300-320
6. Miettinen TA, Tilvis RS, Kesäniemi YA (1990) Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131: 20-31
7. Björkhem I, Miettinen TA, Reihner E, Ewerth S, Angelin B, Einarsson K (1987) Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 28: 1137-1143
8. Kempen HJ, Glatz JF, Gevers Leuven JA, van der Voort HA, Katan MB (1988) Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 29: 1149-1155
9. Miettinen TA (1988) Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 29: 43-51
10. Gylling H, Miettinen TA (1994) Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37: 773-780
11. Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
12. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307
13. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E, for the Cholesterol and Recurrent Events Trial Investigators (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001-1009
14. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr, for the AFCAPS/TexCAPS Research Group (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 279: 1615-1622
15. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339: 1349-1357
16. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D, Shurzinske L, McCormick LS, for the Atorvastatin versus Revascularization Treatment Investigators (1999) Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 341: 70-76
17. National Cholesterol Education Program (1994) Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 89: 1329-1445
18. Molgaard J, von Schenck H, Olsson AG (1989) Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia. Eur J Clin Pharmacol 36: 455-460
19. Miettinen TA, Strandberg T, Vanhanen H, Gylling H, for the 4S Group (1996) Non-cholesterol serum sterols in Scandinavian Simvastatin Survival Study. In: Gotto Jr AM, Paoletti R, Smith LC, Catapano AI, Jackson AS (eds) Drugs affecting lipid metabolism. Risk factors and future directions. Kluwer Academic Publishers, Medical Science Symposium series, Dordrecht, pp 473-476
20. Miettinen TA (1991) Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor. Eur J Clin Pharmacol 40 (Suppl 1): S19-S21
21. Uusitupa MI, Miettinen TA, Happonen P, Ebeling T, Turtola H, Voutilainen E, Pyörälä K (1992) Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum. Arterioscler Thromb 12: 807-813
22. Miettinen TA, Vanhanen H, Ojala J-P, Tikkanen MJ (1992) Noncholesterol sterols and faecal elimination of cholesterol during statin and fibrate treatment. Atherosclerosis 97: S73-S80
23. Vanhanen HT, Miettinen TA (1995) Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination. Atherosclerosis 115: 135-146
24. Gylling H, Miettinen TA (1995) The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level. Atherosclerosis 117: 305-308